Cystic Fibrosis (CF) is a monogenic, lethal disease caused by mutations in the cystic fibrosis transmembrane conductance (CFTR) gene. Here we report the production of CF-iPS cell lines from two different p.F508del homozygous female patients (Table 1). Two different primary cell types, skin fibroblasts and keratinocytes, were transfected with retroviral cocktails containing four: c-MYC, KLF4, OCT4 and SOX2 (MKOS) or three: KLF4, OCT4 and SOX2 (KOS) reprogramming factors. Two fibroblast-derived MKOS lines are described in the main text. The lines carry the p.F508del mutation, have a normal karyotype, express pluripotency markers and are able to differentiate into the three germ layers.
Pubmed ID: 29554588 RIS Download
Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.
This unknown targets Rat IgG (H+L)
View all literature mentionsThis polyclonal secondary targets IgG (H+L)
View all literature mentionsThis unknown targets Goat IgG (H+L)
View all literature mentionsThis polyclonal secondary targets IgG (H+L)
View all literature mentionsThis polyclonal secondary targets IgG (H+L)
View all literature mentionsThis polyclonal targets Human SOX17
View all literature mentionsThis polyclonal targets Alpha-1-fetoprotein
View all literature mentionsThis monoclonal targets Actinin, alpha
View all literature mentionsThis monoclonal targets GATA-4 (G-4)
View all literature mentionsThis monoclonal targets Neuronal Class III beta-Tubulin
View all literature mentionsThis unknown targets Nestin
View all literature mentionsThis monoclonal targets TRA-1-81 clone TRA-1-81
View all literature mentionsThis monoclonal targets HSP90B1
View all literature mentionsThis monoclonal targets Stage-Specific Embryonic Antigen-4
View all literature mentionsThis monoclonal targets Stage-Specific Embryonic Antigen-3
View all literature mentionsThis polyclonal targets Nanog
View all literature mentionsThis monoclonal targets Oct-3/4
View all literature mentions